The Discovery
The Evidence
Products
FACE TREATMENT
ADVANCED FORMULA
HAND TREATMENT
EYE TREATMENT
ANTI-OXIDANT BOOST
REDNESS RELIEF
In the Press
Featured Sellers
Skincare Professional Testimonials
FAQ
Contact Us
Home
Click here to watch our 3-minute movie

Dynamis Skin Science, Inc.
The Pavilion
261 Old York Road
Suite 427
Jenkintown, PA 19046
(877) 682-7949

Questions?


Dynamis Skin Science is a subsidiary of Dynamis Therapeutics, Inc., an early stage pharmaceutical company. Dynamis Therapeutics was founded by a team of scientists as a joint venture between Fox Chase Cancer Center (FCCC) in Philadelphia and a group of investors. It was originally funded by the Ben Franklin Technology Center, the National Institutes of Health as well as venture capital. The company scientists focused on the discovery and development of therapeutic pharmaceuticals to treat and prevent diabetic complications resulting from glucose induced glycation and oxidative stress.


While testing compounds that might reduce these complications in diabetes, scientists from Philadelphia's Fox Chase Cancer Center unexpectedly noticed that a test compound had favorable effects on the texture and elasticity of skin. Further research and development resulted in Supplamine®, which address the effects on skin resulting from glycation and oxidative stress. As a result, Dynamis Skin Science was established to develop and market MEG 21 products containing Supplamine® to doctors and skin care professionals.

Dynamis Skin Science has its offices in Jenkintown, Pennsylvania (just north of Philadelphia). A percentage of the sale of the Dynamis Skin Science products is paid to Fox Chase Cancer Center to support continued basic cancer research.



Copyright © Dynamis Skin Science, Inc.

Face Treatment Advanced Formula